Tumor mutational landscape is a record of the pre-malignant state

Kübler K*, Karlić R*, Haradhvala NJ, Ha K, Kim J, Kuzman M, Jiao W, Gakkhar S, Mouw KW, Braunstein LZ, Elemento O, Biankin AV, Rooman I, Miller M, Karthaus WR, Nogiec CD, Juvenson E, Curry E, Mino- Kenudson M, Ellisen LW, Brown R, Gusev A, Tomasetti C, Lolkema MP, Steeghs N, Van Herpen C, Kim H, Lee H, Vlahoviček K, Bernstein BE, Sawyers CL, Hoadley KA, Cuppen E, A Koren, Arndt PF, Louis DN, Stein LD, Foulkes WD#, Polak P#, Getz G#^, PCAWG Pathology and Clinical Correlates Working Group, ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Network
bioRxiv (2019)


Chromatin structure has a major influence on the cell-specific density of somatic mutations along the cancer genome. Here, we present a pan-cancer study in which we searched for the putative cancer cell-of-origin of 2,550 whole genomes, representing 32 cancer types by matching their mutational landscape to the regional patterns of chromatin modifications ascertained in 104 normal tissue types. We found that, in almost all cancer types, the cell-of-origin can be predicted solely from their DNA sequences. Our analysis validated the hypothesis that high-grade serous ovarian cancer originates in the fallopian tube and identified distinct origins of breast cancer subtypes. We also demonstrated that the technique is equally capable of identifying the cell-of-origin for a series of 2,044 metastatic samples from 22 of the tumor types available as primaries. Moreover, cancer drivers, whether inherited or acquired, reside in active chromatin regions in the respective cell-of-origin. Taken together, our findings highlight that many somatic mutations accumulate while the chromatin structure of the cell-of-origin is maintained and that this historical record, captured in the DNA, can be used to identify the often elusive cancer cell-of-origin.

Getz Lab Authors
* First Authors
# Senior Authors
^ Corresponding Authors
Full text
(# of citations)